Full Text View
Tabular View
No Study Results Posted
Related Studies
Preoperative Octreotide Treatment of Acromegaly (POTA)
This study is ongoing, but not recruiting participants.
Study NCT00521300   Information provided by St. Olavs Hospital
First Received: August 24, 2007   Last Updated: January 22, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acromegaly
Additional conditions recognized in this trial
Growth Hormone-Secreting Pituitary Adenoma
More general conditions related to this trial
Adenoma
Bone Diseases
Bone Diseases, Endocrine
Brain Diseases
Central Nervous System Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Hyperpituitarism
Hypothalamic Diseases
Musculoskeletal Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Nervous System Diseases
Pituitary Diseases
Pituitary Neoplasms
Interventions listed in this trial
Octreotide
Direct surgery for acromegaly
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
St. Olavs Hospital
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services